Search

Your search keyword '"Dubus, Estelle"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Dubus, Estelle" Remove constraint Author: "Dubus, Estelle"
45 results on '"Dubus, Estelle"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

4. Data from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

5. Supplementary Figure 1 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

6. Supplementary Figure 2 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

7. Supplementary Methods and Materials from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

8. Supplementary Figure 4 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

9. Supplementary Tables 1-4 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

10. Supplementary Figure 6 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

11. Supplementary Figure 5 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

12. Supplementary Figure 7 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

13. Supplementary Figure 3 from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

14. Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumors

15. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

20. Additional file 1 of Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation

26. ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations

27. In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice

28. Establishment and characterization ofin vivoorthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

29. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

31. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion

32. Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

33. Establishment and characterization of <italic>in vivo</italic> orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.

35. Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors

38. Abstract 5671: Enhanced activity of pre-activated oxazaphosphorine prodrugs designed for drug delivery strategy: influence of the length of the engrafted group.

39. Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth

43. Inhibition of the NOTCH pathway using -secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors

44. Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies.

45. Establishment and characterization of new orthotopic and metastatic neuroblastoma models.

Catalog

Books, media, physical & digital resources